Recent Posts
- Adcendo ApS Announces FDA Fast Track Designation Granted to ADCE-D01 for the Treatment of Soft Tissue Sarcoma
- Adcendo ApS to Participate in Upcoming September Investor Conferences
- Adcendo ApS Announces First Patient Dosed in Phase I/II ADCElerate1 Trial of ADCE-D01
- Adcendo ApS to Present Data on its Clinical Stage ADCs ADCE-T02 and ADCE-D01 at the 2025 American Association for Cancer Research (AACR) Annual Meeting
- Adcendo ApS Announces Changes in Board of Directors and Strengthens Executive Leadership Team
Recent Comments
No comments to show.